Meg Wood

Director/Miembro de la Junta en

Aronora, Inc.

Health Technology

Finance

Consumer Services

Perfil

Meg Wood is a venture capital business development executive with experience creating emerging growth strategies for portfolio investment.
As the Managing Director of NYBC Ventures, Meg oversees deal execution and management.
Board Observer for NYBC Ventures portfolio companies Catena Biosciences and KaloCyte.
Previously, Meg built and managed a $50 million fund for scientific research and innovation for a rare disease as the Vice President of Business Development at CD Ventures.
She has deep experience deploying investment capital for mission-oriented fund structures.
Prior to her role at CD Ventures, she held positions at MPM Capital, Tufts Medical Center and Boston Medical Center.
She received Master’s degrees in social work and public health from Boston University and her BA from the College of Charleston.

Cargos activos de Meg Wood

Empresas	Cargo	Inicio
Nybc Ventures Nybc Ventures Investment ManagersFinance NYBC Ventures invests in companies located in the United States. The firm targets companies operating in the fields of blood & cellular therapies and related technologies. It provides financing for early stage capital requirements.	Inversor de Capital Privado	01/04/2022
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Inversor de Capital Privado	01/09/2021
Aronora, Inc. Aronora, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of biologic drugs	Director/Miembro de la Junta	01/07/2023
Rarebase, PBC Rarebase, PBC BiotechnologyHealth Technology Provides drug discovery services	Consultor / Asesor	01/08/2021
Thymmune Therapeutics Thymmune Therapeutics BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company that develops regenerative thymic cell therapies for the treatment of posttransplant organ tolerance, immunodeficiencies and autoimmune diseases	Director/Miembro de la Junta	01/03/2023
KaloCyte, Inc. KaloCyte, Inc. BiotechnologyHealth Technology Develops red blood cell substitutes used for trauma care related treatments	Director/Miembro de la Junta	01/05/2022

Todos los cargos activos de Meg Wood

Antiguos cargos conocidos de Meg Wood.

Empresas	Cargo	Fin
CureDuchenne Ventures LLC CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements.	Inversor de Capital Privado	01/08/2021
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Inversor de Capital Privado	01/06/2016
Catena Biosciences, Inc. Catena Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics through protein conjugation technologies	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Meg Wood.

Formación de Meg Wood.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Meg Wood.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	11
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Health Services
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Finance
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
College of Charleston College of Charleston Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CureDuchenne Ventures LLC CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements.	Finance
KaloCyte, Inc. KaloCyte, Inc. BiotechnologyHealth Technology Develops red blood cell substitutes used for trauma care related treatments	Health Technology
Aronora, Inc. Aronora, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of biologic drugs	Health Technology
Rarebase, PBC Rarebase, PBC BiotechnologyHealth Technology Provides drug discovery services	Health Technology
Catena Biosciences, Inc. Catena Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics through protein conjugation technologies	Health Technology
Thymmune Therapeutics Thymmune Therapeutics BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company that develops regenerative thymic cell therapies for the treatment of posttransplant organ tolerance, immunodeficiencies and autoimmune diseases	Health Technology
Nybc Ventures Nybc Ventures Investment ManagersFinance NYBC Ventures invests in companies located in the United States. The firm targets companies operating in the fields of blood & cellular therapies and related technologies. It provides financing for early stage capital requirements.	Finance